Targeting of high-capacity adenoviral vectors

Human Gene Therapy

Volumn 12, Issue 14, 2001, Pages 1757-1769

  Biermann, Volker ^a   Volpers, Christoph ^a   Kewes, Helmut ^a   Schiedner, Gudrun ^a   Kochanek, Stefan ^a   Hussmann, Steffi ^b   Stock, Anke ^b   Herrmann, Andreas ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Cardion AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS RECEPTOR; ARGINYLGLYCYLASPARTIC ACID; BETA GALACTOSIDASE; COXSACKIE VIRUS RECEPTOR; EPITOPE; HISTIDINE; INTEGRIN; PEPTIDE; PROTEIN KNOB; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR; VIRUS VECTOR;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE AMPLIFICATION; GENE INSERTION; GENE TARGETING; HELPER VIRUS; HUMAN; HUMAN CELL; NONHUMAN; OVARY CARCINOMA; PLASMID; PROTEIN DOMAIN; PROTEIN EXPRESSION; SAFETY; SMOOTH MUSCLE FIBER; VIRUS CAPSID; VIRUS INFECTIVITY;

ADENOVIRIDAE; BETA-GALACTOSIDASE; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELLS, CULTURED; CLONING, MOLECULAR; ENDOTHELIUM; EPITOPES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; HELPER VIRUSES; HUMANS; LIGANDS; MODELS, GENETIC; MUSCLE, SMOOTH; OLIGOPEPTIDES; PEPTIDES; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034803805     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750476258     Document Type: Article

References (52)

1. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
2. Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid
3. Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: Regulation in response to cell density
4. Persistence in muscle of an adenoviral vector that lacks all viral genes
5. 5 integrin
6. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
7. Targeted gene delivery by tropism-modified adenoviral vectors
8. Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base
9. v-integrin does not correlate with adenovirus targeting in vivo indicating anatomical vector barriers
10. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes
11. Targeted gene delivery to kaposi’s sarcoma cells via the fibroblast growth factor receptor
12. Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells
13. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli
14. Techniques for human adenovirus vector construction and characterization
15. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
16. High-capacity adenoviral vectors for gene transfer and somatic gene therapy
17. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase
18. Phage libraries displaying cyclic peptides with different ring sizes: Ligand specificities of the RGD-directed integrins
19. Identification of receptor ligands with phage display peptide libraries
20. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
21. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob
22. G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligands
23. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector
24. Addition of a short peptide ligand to the adenovirus fiber protein
25. 1-antitrypsin with negligible toxicity
26. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
27. An adenoviral vector deleted for all coding sequences results in enhanced safety and extended expression of a leptin transgene
28. Expanded-capacity adenoviral vectors-The helper-dependent vectors
29. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
30. v Integrins as receptors for tumor targeting by circulating ligands
31. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer
32. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and reduced toxicity
33. Efficient transformation of primary human amniocytes by E1 functions of Ad5: Generation of new cell lines for adenoviral vector production
34. + cells by a retargeted adenovirus vector
35. Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens
36. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
37. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases
38. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
39. RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection
40. Adenovirus vector pseudotyp-ing in fiber-expressing cell lines: Improved transduction of Epstein-Barr virus-transformed B cells
41. The ’adenobody’ approach to viral targeting: Specific and enhanced adenoviral gene delivery
42. 5 promote adenovirus internalization but not virus attachment
43. 5 selectively promotes adenovirus mediated cell membrane permeabilization
44. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs
45. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
46. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies
47. Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation
48. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
49. Crystal structure of the receptor-binding domain of adeno-virus type 5 fiber protein at 1.7 A resolution
50. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma
51. A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia